Patients with large-cell neuroendocrine lung carcinoma or small-cell lung cancer with KL expression have better outcome than those without KL expression pointing to KL being a potential biomarker (Usuda et al., 2011a; Vanoirbeek et al., 2011; Brominska et al., 2019). Here, KL is linked to small cell lung carcinoma.